Can-Fite BioPharma Ltd.
CANF
$1.20
-$0.03-2.44%
AMEX
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.60% | -50.83% | 11.71% | -20.86% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 12.11% | -14.93% | -19.15% | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -1.28% | -- | 65.96% | -- | |
| Total Current Assets | -9.35% | -46.58% | 8.20% | -13.19% | |
|
|
|||||
| Total Current Assets | -9.35% | -46.58% | 8.20% | -13.19% | |
| Net Property, Plant & Equipment | 70.37% | -23.58% | -35.71% | -14.55% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | -8.70% | -46.32% | 7.61% | -13.20% | |
|
|
|||||
| Total Accounts Payable | 44.73% | 9.26% | -52.34% | 82.63% | |
| Total Accrued Expenses | 3.39% | -27.85% | 21.81% | 50.16% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 96.30% | -18.18% | -43.75% | 20.00% | |
| Total Finance Division Other Current Liabilities | -34.89% | -18.77% | -20.56% | -18.36% | |
| Total Other Current Liabilities | -34.89% | -18.77% | -20.56% | -18.36% | |
| Total Current Liabilities | 1.58% | -11.02% | -19.26% | 29.87% | |
|
|
|||||
| Total Current Liabilities | 1.58% | -11.02% | -19.26% | 29.87% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 292.31% | -4.55% | -7.14% | -58.06% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -7.71% | -24.59% | -25.36% | -20.52% | |
| Total Liabilities | -1.66% | -17.20% | -22.14% | -0.51% | |
|
|
|||||
| Common Stock & APIC | 4.32% | 1.85% | 6.10% | 8.41% | |
| Retained Earnings | -4.97% | -4.75% | -5.06% | -10.35% | |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | |
| Total Common Equity | -12.93% | -63.94% | 39.60% | -20.42% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -12.93% | -63.94% | 39.60% | -20.42% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -12.93% | -63.94% | 39.60% | -20.42% | |
|
|
|||||